1. Home
  2. IPG vs VTRS Comparison

IPG vs VTRS Comparison

Compare IPG & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPG
  • VTRS
  • Stock Information
  • Founded
  • IPG 1902
  • VTRS 1961
  • Country
  • IPG United States
  • VTRS United States
  • Employees
  • IPG N/A
  • VTRS N/A
  • Industry
  • IPG Advertising
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • IPG Consumer Discretionary
  • VTRS Health Care
  • Exchange
  • IPG Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • IPG 12.0B
  • VTRS 12.9B
  • IPO Year
  • IPG N/A
  • VTRS N/A
  • Fundamental
  • Price
  • IPG $27.10
  • VTRS $12.83
  • Analyst Decision
  • IPG Hold
  • VTRS Hold
  • Analyst Count
  • IPG 8
  • VTRS 3
  • Target Price
  • IPG $31.25
  • VTRS $13.33
  • AVG Volume (30 Days)
  • IPG 4.4M
  • VTRS 7.1M
  • Earning Date
  • IPG 10-22-2024
  • VTRS 11-07-2024
  • Dividend Yield
  • IPG 4.87%
  • VTRS 3.74%
  • EPS Growth
  • IPG N/A
  • VTRS N/A
  • EPS
  • IPG 2.13
  • VTRS N/A
  • Revenue
  • IPG $9,338,900,000.00
  • VTRS $15,048,500,000.00
  • Revenue This Year
  • IPG N/A
  • VTRS N/A
  • Revenue Next Year
  • IPG N/A
  • VTRS N/A
  • P/E Ratio
  • IPG $12.70
  • VTRS N/A
  • Revenue Growth
  • IPG N/A
  • VTRS N/A
  • 52 Week Low
  • IPG $27.01
  • VTRS $9.08
  • 52 Week High
  • IPG $35.17
  • VTRS $13.62
  • Technical
  • Relative Strength Index (RSI)
  • IPG 22.39
  • VTRS 62.35
  • Support Level
  • IPG $29.04
  • VTRS $11.33
  • Resistance Level
  • IPG $29.49
  • VTRS $13.09
  • Average True Range (ATR)
  • IPG 0.61
  • VTRS 0.43
  • MACD
  • IPG -0.18
  • VTRS 0.10
  • Stochastic Oscillator
  • IPG 2.26
  • VTRS 71.09

About IPG Interpublic Group of Companies Inc. (The)

Interpublic Group is among the world's largest advertising holding companies based on annual revenue. It provides traditional advertising services along with digital and other services such as public relations through various acquisitions. IPG has made these services available in over 100 countries. The company generates about 65% of revenue in the US and 17% in the UK and Europe.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: